IP Library Granted Patent US 8,034,363
Granted Patent B2
US 8,034,363 · App. 12/332,414 · Granted Oct 11, 2011

Sustained release systems of ascorbic acid phosphate

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,363
App. No.
12/332,414
Granted
Oct 11, 2011
Kind
B2
Abstract

A novel method of preparing a controlled release composition is disclosed. Specifically, the present invention relates to a method of preparing controlled release compositions of ascorbic acid phosphate and absorbable polymers. Also disclosed is a novel controlled release composition of ascorbic acid phosphate made by the method of the present invention.

Claims (13)

1. A method of making a controlled release composition of ascorbic acid phosphate, comprising the steps of:

drying ascorbic acid phosphate at a temperature of no greater than about 160° C. for about 30 min; and,

melt blending the dried ascorbic acid phosphate with an absorbable aliphatic polyester polymer at a temperature of no greater than about 160° C. to form an ascorbic acid phosphate and polymer composition.

2. The method of claim 1 , comprising the additional step of processing the ascorbic acid and polymer composition into a desired form at a temperature of no greater than about 160° C.

3. The method of claim 1 where the composition comprises ascorbic acid in the amount of about 0.5 wt % to about 20 wt % of the composition.

4. The method of claim 1 where the composition comprises ascorbic acid in the amount of about 2 wt % to about 10 wt % of the composition.

5. The method of claim 1 where the absorbable aliphatic polyester polymer is a homopolymer or copolymer prepared from monomers selected from the group consisting of lactide, glycolide, epsilon-caprolactone, dioxanone, and trimethylene carbonate.

6. The method of claim 1 where the absorbable aliphatic polyester polymer is a copolymer prepared from epsilon-caprolactone and glycolide.

7. The method of claim 2 , wherein the composition is formed into a medical device selected from the group consisting of fibers, rods, screws, staples, suture anchors, films and combinations thereof.

8. The method of claim 1 , wherein the absorbable polymer and the ascorbic acid phosphate are melt blended for about 5 minutes to about 30 minutes.

9. The method of claim 1 , additionally comprising the step of combining the composition with at least one bioactive agent.

10. The method of claim 1 , additionally comprising the step of combining the composition with viable tissue.

11. The method of claim 1 , additionally comprising the step of combining the composition with cells.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2013
From: ADVANCED TECHNOLOGIES AND REGNERATIVE MEDICINE, LLC
To: ETHICON, INC.
Reel/Frame 029595/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2012
From: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
To: ETHICON, INC.
Reel/Frame 029496/0269 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2011
From: ETHICON, INC.
To: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
Reel/Frame 026286/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2011
From: ETHICON, INC.
To: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC.
Reel/Frame 026273/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2009
From: LI, YUFU; WOHLERT, STEPHEN; YANG, CHUNLIN
To: ETHICON, INC.
Reel/Frame 022258/0495 →